China Diagnostic Reagent Industry Report, 2012-2014
Published Date » 2013-01-04
No. Of Pages » 86
Chinas diagnostic reagent industry has formed a certain market scale and basis, and is marching from the introduction stage to the growth stage. With the continuous growth in Chinas medical care investment and per capita health care spending, the Chinas diagnostic reagent market has a promising prospect.
In vitro diagnostic reagents account for more than 90.0% of the output of Chinas diagnostic reagent industry. In 2011, the market scale of in vitro diagnostic reagents reached about RMB 11.4 billion in China, the industry will maintain a growth rate of 15%-20% in the future, and the market scale will hit RMB 20.8 billion in 2015.
At present, there are only a few integrated in vitro diagnostic reagent enterprises with strong strength in Chinas diagnostic reagent market, including KHB and Fosun Pharma; other enterprises such as Da An Gene, BioSino, Leadman and Livzon have competitive advantages in specific fields such as biochemical diagnosis, immunodiagnosis, and molecular diagnosis. Meanwhile, Chinas in vitro diagnostic reagent industry concentration is low. Among 300-400 enterprises, there are only about 20 enterprises with annual sales of more than RMB 100 million. The enterprises are generally small and have a few product varieties. In 2011, KHB, Da An Gene, BioSino, Leadman only occupied 3.8%, 2.3%, 1.9%, 1.6% of the market respectively.
As a high-tech industry, the profitability of the overall Chinese diagnostic reagent industry is high. In 2011, among major Chinese diagnostic reagent enterprises, KHB, Da An Gene, BioSino, Kinghawk, Livzon, Leadman all achieved a gross margin of more than 50%; Fosun Pharma reached a gross margin of 40.4%, since diagnostic reagent and instrument business accounts for a lower proportion of its revenue. With the improvement of industry concentration, its expected that the advantageous enterprises with strong capability of technological innovation and large production scale will obtain higher market share and profitability.
China Diagnostic Reagent Industry Report, 2012-2014 mainly includes the following contents:
- Market scale, market structure, import and export, competitive landscape, profitability, entry barriers of Chinas diagnostic reagent industry;
- Regulatory system and policy, industry policy, industrial chain, upstream and downstream of Chinas diagnostic reagent industry;
- Development forecast of Chinas diagnostic reagent industry, including the forecast of market scale, major market segments, industry competition, and enterprise development trends;
- Production, operation, investment, M&A, diagnostic reagent business and development prospect of 15 Chinese diagnostic reagent enterprises.
Table of Content
1. Overview of Diagnostic Reagent Industry
2. China Diagnostic Reagent Industry
2.2 Market Structure
2.3 Import and Export
2.4 Competitive Landscape
2.4.1 Biochemical Diagnostic Reagents
2.4.2 Immune Diagnostic Reagents
2.4.3 Molecular Diagnostic Reagents
2.4.4 Integrated In Vitro Diagnostic Reagents
2.6 Entry Barriers
2.6.1 Technical Barriers
2.6.2 Quality and Brand Barriers
2.6.3 Marketing Channel Barriers
2.6.4 Market Access Barriers
3. Development Environment of China Diagnostic Reagent Industry
3.1 Policy Environment
3.1.1 Regulatory Policy
3.1.2 Industry Policy
3.2 Upstream and Downstream Industries
3.2.1 Industrial Chain
4. Development Forecast of China Diagnostic Reagent Industry
4.1 Overall Forecast
4.1.1 Market Demand Drivers
4.1.2 Market Scale Forecast
4.2 Development Trends of Diagnostic Reagent Industry
4.2.1 Biochemical Diagnosis and Immunodiagnosis Will Still Be the Mainstream
4.2.2 Industry Concentration Will Increase
4.2.3 Enterprises with Complete Product Line Integrating Reagents and Instruments will Win
5. Major Chinese Diagnostic Reagent Enterprises
5.1 Shanghai Kehua Bio-engineering Co., Ltd. (KHB)
5.1.3 Revenue Structure
5.1.4 Gross Margin
5.1.5 R & D and Investment
5.1.7 Diagnostic Reagent Business
5.1.8 Forecast and Prospect
5.2 Da An Gene Co., Ltd.
5.2.3 Revenue Structure
5.2.4 Gross Margin
5.2.5 R & D and Investment
5.2.6 Diagnostic Reagent Business
5.2.7 Forecast and Prospect
5.3 Shanghai Fosun Pharmaceutical (Group) Co., Ltd.
5.3.3 Revenue Structure
5.3.4 Gross Margin
5.3.5 R & D and Investment
5.3.6 Diagnostic Reagent Business
5.3.7 Forecast and Prospect
5.4 BioSino Bio-technology and Science Inc.
5.4.3 Revenue Structure
5.4.4 R & D and Investment
5.4.5 Forecast and Prospect
5.5 Beijing Kinghawk Pharmaceutical Co., Ltd.
5.5.3 Revenue Structure
5.5.4 Gross Margin
5.5.5 Diagnostic Reagent Business
5.5.6 Forecast and Prospect
5.6 Livzon Pharmaceutical Group Inc.
5.6.3 Revenue Structure
5.6.4 Gross Margin
5.6.5 Diagnostic Reagent Business
5.6.6 Forecast and Prospect
5.7 Beijing Leadman Biochemistry Co., Ltd.
5.7.3 Revenue Structure
5.7.4 Gross Margin
5.7.5 R & D and Investment
5.7.7 Diagnostic Reagent Business
5.7.8 Forecast and Prospect
5.8 Acon Biotech (Hangzhou) Co., Ltd.
5.9 Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.
5.10 Shanghai Rongsheng Biotech Co., Ltd. (Rsbio)
5.11 Shenzhen PG Biotech Co., Ltd.
5.12 Shanghai Upper Bio-Tech Pharma Co., Ltd.
5.13 Inverness Medical (Shanghai) Co., Ltd.
5.14 Blue Cross Bio-Medical (Beijing) Co., Ltd.
5.15 Beijing North Institute of Biological Technology (BNIBT)
List of TablesNA
List of FiguresNA
Wound Care Sealants Market - Global Industry Analysis, Size, Share, Growth, Trends And Forecast, 2013 - 2019
By - Transparency Market Research
Would heal or wound repair is the physiological process by which the body repairs organ tissue or skin after injury. The wound healing process is divided in to four sequential steps namely hemostasis, inflammatory, proliferative and remodeling. Hemostasis is the first step that begins immediately after injury followed by fibrin clot formation. Clot formation takes place within fraction of minutes to control the blood loss. Hence, disturbed wound healing process can be related with increased mortality rate. The improved understanding of wound healing has resulted in the rapid...
Intelligent and Secured Networks Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2012 - 2018
By - Transparency Market Research
An intelligent and secured network provides security, flexibility, robustness and personalized solutions to the users. It is used to curb web attacks, windows exploits, network attacks etc. These networks help prevent frauds, information leakage and also help increase security and performance of devices. Some of the drivers pushing the growth of these networks include rise in hacktivism, increasing anonymous proxies, growth in IT organizations etc. One of the restraints which may limit the growth is the high installation and configuration costs of networks. There...
Human Embryonic Stem Cells Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019
By - Transparency Market Research
Human embryonic stem cells (hESCs) are derived from blastocyst and are capable of differentiating into number of cell types that make up the human body. hESCs can replicate indefinitely and produce non-regenerative tissues such as neural and myocardial cells. These abilities of human embryonic stems cells allow them to be used as a tool in regenerative medicine and research. Because of their capacity for self-renewal, they can be used in treating a number of blood and genetic disorders related to the immune system, cancers, and disorders. Human embryonic stem cells are also used in...
We will be happy to help you find what you need.
Please call us or write us:
Please call us or write us:
866-997-4948 (Us-Canada Toll Free)
Select License type:
- Global and China Dental Implants Industry 2014 Market Research Report
- Global and China Liquid Crystal Display Television Industry 2014 Market Research Report
- Global and China Tail tank Industry 2014 Market Research Report
- Global and China Positive Airway Pressure Devices Industry 2014 Market Research Report
- Global and China Horizontal stabilizer Industry 2014 Market Research Report
- Global and China Dental Biomaterial Industry 2014 Market Research Report
- Global and China Auxiliary tank Industry 2014 Market Research Report
- Global and China Alternate tank Industry 2014 Market Research Report
- Global and China Dental Imaging Industry 2014 Market Research Report
- Global and China Main tank Industry 2014 Market Research Report
India is Facing a Cancer Crisis
Apr 15, 2014
India is currently facing a cancer crisis – reports a recent research carried out at the King’s college London, in collaboration with the Tata Memorial Cancer Centre, Mumbai. The reasons estimated for this crisis comprise of increasing rates of smoking, unequal access to proper treatment and belated diagnosis. Every year, India witnesses around one...
Microparticle Tags to Check Counterfeit Goods Invented
Apr 14, 2014
Researchers from the Massachusetts Institute of Technology have invented a new set of microparticles that can easily be read by smartphones and establish the authenticity of currency, electronic items and luxury goods. This strategy is among those countless measures taken by big brands and companies to label their legitimate products in order to stop illegal copies of the...
USFDA Approves Lupins Generic Diabetic Drug
Apr 10, 2014
The United States Food and Drugs Administration (USFDA) has finally approved Lupin Pharmaceuticals Inc (LPI), the American subsidiary of Indian drug manufacturers Lupin Ltd, to sell Pioglitazone Tablets in the U.S market. The approval has been granted first for fiscal 2015. Pioglitazone is a generic medicine used for managing diabetes and is a version of Actos tablets...
Infrared Sensors can Soon Be Used to Develop Night-Vision Lenses - A New Discovery Confirms
Apr 8, 2014
People who fear the dark may soon have a reason to rejoice – an infrared sensor that can eventually be used for mechanizing night-vision lenses has been developed. This effectively means that one can also see through dark with the help of these lenses. This technology seems possible all due to graphene, a layer of tightly packed carbon atoms that has allowed the creation of...
Ontarios thanks Sustainable Development Technology Canada for Clean Tech Ecosystem Movements
Apr 8, 2014
Sustainable Development Technology Canada has leveraged an extra $2.2 billion in funding from project partners that also includes global clean technology companies. Sustainable Development Technology Canada (SDTC) is energizing and evolving the development and demonstration of a clean technology ecosystem. They are the vital contributors to the prominent concentration of clean...